PISCATAWAY, N.J. - October 17, 2017 (Investorideas.com newswire) IEEE, the world's largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Standards Association (IEEE-SA), today announced the upcoming publication of a report entitled: The State of Blockchain Adoption on the Pharmaceutical Supply Chain. The independent study, a first-of-its-kind, examines the barriers and perceived benefits of adopting the technology with insights from industry executives currently exploring use cases or testing blockchain in their operations. The study cuts to the core of key protocol and process questions addressing barriers to advancing industry-wide consideration and adoption of the technology.
"This unique study further highlights IEEE's commitment to better understand the pharmaceutical industry's concerns with adopting new technologies in their heavily regulated and complex global supply chain operation," said Tim Mackey, co-chair of the IEEE-SA's Supply Chain/Clinical Trials Technology Implementation Industry Connections Program. “This formal evaluation of the challenges and benefits of blockchain is a valuable information resource for the IEEE, as well as regulators, technology developers and the industry, that further emphasizes a need for more awareness and education to help build consensus for standards development that advances enterprise adoption."
The framework for the study originated with common themes unveiled at the first IEEE Pharma Supply Blockchain Forum, which took place on 6 June 2017 on the campus of John Hopkins University in Rockville, MD. Forum attendees included regulators and executives from manufacturers, wholesalers and dispensaries—key partners on the pharmaceutical supply chain—exploring how blockchain can optimize operations and better secure the supply chain to combat the rising epidemic of counterfeit medicine.
The U.S.-based study reached 300 qualified executives familiar with blockchain applications on the pharmaceutical supply chain, and highlights the confidence level of trust amongst trusted partners in an autonomous, decentralized system, as well as exploring the dynamics of finance, data ownership and beneficiaries. The intended purpose of the study is to expose what is needed to increase confidence in the technology and advance its adoption to achieve the desired outcome of securing and optimizing the pharmaceutical supply chain, and ultimately improving upon patient care. More information regarding the study is available on IEEE's blockchain website. The full report will be available for purchase in October 2017.
IEEE will be hosting a half-day workshop highlighting sections of the report on Day One of the HDA's (Healthcare Distribution Alliance) 8th Annual Traceability Seminar to be held 8-10 November 2017 at the Renaissance Washington, D.C. Downtown Hotel. See more information and/or register for this workshop.
To learn more about IEEE-SA, visit us on Facebook, follow us on Twitter, connect with us on LinkedIn or on the Beyond Standards Blog.
About the IEEE Standards Association
The IEEE Standards Association, a globally recognized standards-setting body within IEEE, develops consensus standards through an open process that engages industry and brings together a broad stakeholder community. IEEE standards set specifications and best practices based on current scientific and technological knowledge. The IEEE-SA has a portfolio of over 1,200 active standards and over 650 standards under development. For more information visit http://standards.ieee.org.
IEEE is the largest technical professional organization dedicated to advancing technology for the benefit of humanity. Through its highly cited publications, conferences, technology standards, and professional and educational activities, IEEE is the trusted voice in a wide variety of areas ranging from aerospace systems, computers, and telecommunications to biomedical engineering, electric power, and consumer electronics. Learn more at http://www.ieee.org.
Lloyd Green, +1 732-465-6444
Director, Engagement Marketing & Creative Community Services
Jeff Pane, +1 732-465-6605
Associate Brand and Marketing Communications Manager
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.om newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.